Welcome to LookChem.com Sign In|Join Free
  • or
2-[(2,5-dichlorophenyl)amino]benzoic acid is a chemical compound with the molecular formula C13H8Cl2NO2. It is an organic compound that features a benzoic acid backbone, with an amino group attached to the 2-position and a 2,5-dichlorophenyl group connected to the amino nitrogen. 2-[(2,5-dichlorophenyl)amino]benzoic acid is known for its potential applications in the synthesis of various pharmaceuticals and agrochemicals, particularly as a building block for the creation of compounds with biological activity. Its structure allows for the exploration of different chemical modifications, which can lead to the development of new drugs or pesticides. The compound's properties, such as its reactivity and stability, make it a valuable intermediate in the chemical industry.

6334-92-5

Post Buying Request

6334-92-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6334-92-5 Usage

Type of drug

Nonsteroidal anti-inflammatory drug (NSAID)

Function

Inhibits the production of prostaglandins, which cause pain and inflammation in the body

Common uses

Treatment of conditions such as arthritis, menstrual cramps, and acute injuries

Available forms

Tablets, capsules, and topical gels

Tolerance

Generally well-tolerated

Possible side effects

Stomach upset and increased risk of cardiovascular events

Check Digit Verification of cas no

The CAS Registry Mumber 6334-92-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,3,3 and 4 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 6334-92:
(6*6)+(5*3)+(4*3)+(3*4)+(2*9)+(1*2)=95
95 % 10 = 5
So 6334-92-5 is a valid CAS Registry Number.

6334-92-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(2,5-dichloroanilino)benzoic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6334-92-5 SDS

6334-92-5Relevant academic research and scientific papers

Synthesis, biological evaluation, and molecular modeling of novel thioacridone derivatives related to the anticancer alkaloid acronycine

Dheyongera, James P.,Geldenhuys, Werner J.,Dekker, Theodor G.,Van Der Schyf, Cornelis J.

, p. 689 - 698 (2007/10/03)

The well-reported, but moderate antitumor activity of the acronycine alkaloid led us to synthesize a novel series of thioacridone compounds related to acronycine, as potential anticancer agents. Compounds were designed either as DNA intercalating agents, or as DNA intercalating agents with covalent bond forming potential. Bathochromic shifts of the compounds upon complexation with salmon testis DNA suggested intercalation as the mode of DNA binding. The binding interaction of the compounds was found to be approximately 10 2 M-1, with that of the most potent compound 1-(2-dimethylaminoethylamino)-9(10H)-thioacridone, 104 M -1. In vitro cytotoxic activity (IC50) against HL-60 cells was found to range between 3.5 and 22 μg/mL. QSAR analyses yielded a multiple linear regression equation with an r2 of 0.847 for DNA binding and an r2 of 0.575 for cytotoxicity. The physicochemical parameters used in the QSAR analyses were log P, polar surface area, and calculated molar refractivity. Docking studies were also performed to compare the binding of the most potent and least potent compounds in the study in order to predict desirable chemical characteristics for further exploitation in drug design efforts. The thioacridone compounds in this series demonstrate cytotoxic activity in vitro that merit future in vivo evaluation.

Thyroid hormone uptake by hepatocytes: Structure-activity relationships of phenylanthranilic acids with inhibitory activity

Chalmers,Scholz,Topliss,Kolliniatis,Munro,Craik,Iskander,Stockigt

, p. 1272 - 1277 (2007/10/02)

The synthesis of a series of mono- and disubstituted N-phenylanthranilic acids is described. Substituents on the phenyl ring include Cl, CN, OH, CF3, Br, I, CH3, OCH3, and OCF2CF2H. These compounds have been tested for their inhibitory effect on triiodothyronine (T3) uptake by H4 hepatocytes. The nonsteroidal antiinflammatory drugs flufenamic acid, mefenamic acid, and meclofenamic acid and the structurally related compounds 2,3- dimethyldiphenylamine and diclofenac were also tested. The most potent compounds were found to be, in order of decreasing activity, meclofenamic acid (2,6-Cl2,3-CH3), flufenamic acid (3-CF3), mefenamic acid (2,3- (CH3)2), and the compounds with 3,5-Cl2 and 3-OCF2CF2H substituents. The least potent compounds had 3-CN and 3-OH substituents. An analysis of quantitative structure-activity relationships (QSAR) for the series of phenylanthranilic acids showed that the inhibition of T3 uptake is highly dependent on the hydrophobicity of the compound. The relationship between uptake inhibition and the calculated octanol-water partition coefficient (clogP) was found to be parabolic, with optimum inhibitory activity found when the clogP of the phenylanthranilic acid was 5.7. It was also found that the 1-carboxylic acid group of the phenylanthranilic acids was not a prerequisite for uptake inhibition to occur, but its removal or alteration resulted in reduced inhibition.

Structure-activity relationships in a series of anti-inflammatory N-arylanthranilic acids

Kaltenbronn,Scherrer,Short,Jones,Beatty,Saka,Winder,Wax,Williamson

, p. 621 - 627 (2007/10/02)

A large series of N-arylanthranilic acids has been prepared. Many of these compounds show high anti-inflammatory activity as measured by the anti-UV-erythema test. From this series have come the clinically useful nonsteroidal anti-inflammatory agents, flufenamic acid (Arlef), mefenamic acid (Ponstel), and the latest and most potent agent, N-(2,6-dichloro-m-tolyl)anthranilic acid (meclofenamic acid, Meclomen = the sodium salt). The structure-activity relationships of this series is discussed and a graphical representation is presented which allows the prediction of activity of new agents.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 6334-92-5